Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 525 of 5804
-
Immune cells from your own tumor could fight cancer
Disease control Recruiting nowThis study is a single arm, open design aimed at evaluating the safety and tolerability of Autologous Tumor-Infiltrating Lymphocyte (GT307) for treatment of patients with solid tumours,while evaluating pharmacokinetic characteristics and efficacy assessment to determine the optim…
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
One-Shot stem cell treatment aims to quiet aching backs
Symptom relief OngoingThe primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a single injection of rexlemestrocel-L+HA injected into a lumbar intervertebral disc compared to control th…
Phase: PHASE3 • Sponsor: Mesoblast, Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy aims to stop mesothelioma return after surgery
Disease control Recruiting nowObjectives: The investigators will test whether combination of chemoimmunotherapy or dual agent immunotherapy alone improves efficacy for patients with MPM. Primary Objectives: The primary objective is to test whether the combination of platinum-based chemotherapy and pemetrexe…
Phase: PHASE1, PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New combo therapy aims to keep High-Risk nasopharyngeal cancer at bay
Disease control Recruiting nowPatients with "high-risk" locoregionally-advanced nasopharyngeal carcinoma (LA-NPC), defined as AJCC/UICC 8th edition TNM-stage III-IVA and high Epstein-Barr virus (EBV) DNA viral load (≥4,000 copies/mL) will require induction chemotherapy (IC) prior to chemo-radiation (CCRT) as …
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Eczema drug trial could mean fewer shots for patients
Disease control OngoingThe main purpose of this study is to evaluate the effectiveness of 24 weeks of lebrikizumab in improving disease severity, signs, and symptoms in adults and adolescents with moderate-to-severe AD in Part 1 and to describe how similar is the current maintenance dosing regimen of l…
Phase: PHASE3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New seizure therapy aims to curb suicidal thoughts with fewer side effects
Disease control Recruiting nowThis protocol proposes an initial randomized clinical trial that includes all patients with suicidal ideation (SI) at baseline, and with SI as the primary outcome measure to examine whether Right Unilateral Low-Amplitude Pulse - Seizure Therapy (RUL LAP-ST) treatment has more mag…
Phase: PHASE2, PHASE3 • Sponsor: Michigan State University • Aim: Disease control
Last updated Jun 26, 2026 18:37 UTC
-
Cord blood cells engineered to fight stomach and pancreatic cancers
Disease control CompletedMain Objective: To study the maximum tolerated dose (MTD) and dose-dependent toxicity (DLT) of cord blood-derived CAR-NK cells (CB CAR-NK182) targeting Claudin18.2 in patients with advanced gastric cancer and advanced pancreatic cancer. Secondary Objective: To evaluate the effic…
Phase: PHASE1 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Precision radiation targets hidden prostate cancer spots
Disease control Recruiting nowThe purpose of this prostate cancer research study is to learn about: 1. Improving control of prostate cancer using radiation therapy, delivered to the para-aortic and pelvic lymph nodes, in addition to systemic androgen suppression therapy; 2. Preserving quality of life after r…
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could CAR t cells tame scleroderma? new trial launches
Disease control Recruiting nowRESET-SSc: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T cell therapy, in Subjects with Systemic Sclerosis
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Vitamin d cream plus chemo cream may shield transplant patients from skin cancer
Prevention OngoingThis phase IIA study evaluates the effects of calcipotriene plus 5- fluorouracil immunotherapy for skin cancer prevention in organ transplant recipients. Solid organ transplant recipients are at high risk of developing skin cancer. Actinic keratosis (AK), is a premalignant skin l…
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Could an arthritis drug help fight tough breast cancers?
Disease control Recruiting nowThis is a randomized Phase II study of standard of care (SOC) chemotherapy monotherapy vs. SOC chemotherapy combined with tocilizumab in in Black and non-Black patients with metastatic triple negative or ER low breast cancer.
Phase: PHASE2 • Sponsor: Kathy Miller • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Viagra for the brain? new trial tests sildenafil in chronic TBI patients
Disease control Recruiting nowTraumatic Cerebral Vascular Injury (TCVI) is a common consequence of traumatic brain injury (TBI), including mild TBI (mTBI). TCVI is associated with poor recovery after TBI in animal models. TCVI can be measured non-invasively in humans, and therapies targeting TCVI are attracti…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New Three-Drug cocktail aims to beat back aggressive leukemia before transplant
Disease control Recruiting nowThis study is a single-center, single-arm, prospective phase II clinical trial evaluating the efficacy and safety of the VAH (Venetoclax and Azacitidine combined with Homoharringtonine) regimen, followed by allo-HSCT for intermediate and high-risk AML. Eligible patients receive t…
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New Self-Gripping mesh aims to reduce hernia recurrence in High-Risk patients
Disease control OngoingThe purpose of RECOVER is to evaluate the performance and safety of Transorb™ self-gripping resorbable mesh in high-risk subjects (at least one risk factor impairing wound healing) when used for reinforcement of abdominal wall soft tissues in procedures involving open extraperito…
Phase: NA • Sponsor: Medtronic - MITG • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Immune cell therapy takes on lupus in early trial
Disease control ENROLLING_BY_INVITATIONPrimary objective: Safety and tolerability of NKX019, administered after lymphodepletion (LD). Secondary objectives: * Assess clinical activity of NKX019 in subjects with systemic lupus erythematosus (SLE) with or without active lupus nephritis (LN) * Characterize pharmacokinet…
Phase: PHASE1 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for men with spread prostate cancer: targeted radiation may boost standard care
Disease control Recruiting nowThe purpose of this study is to find out if giving radiation therapy (RT) to areas of metastatic prostate cancer at the time a participant is diagnosed will help control disease better than the usual treatment. This treatment is called metastasis-directed radiotherapy (MDRT). Th…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for Hard-to-Treat breast cancer: Real-World study launches
Disease control Recruiting nowNon-interventional, multicenter, prospective observational study of tucatinib-trastuzumab capecitabine administered according to the standard local clinical practice following approved SmPC indication and dose. About 300 Her2 positive metastatic breast cancer patients who are ca…
Sponsor: Fondazione Oncotech • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Gut feeling: personalized bacteria may ease PTSD symptoms
Disease control OngoingThis cohort clinical trial (RAPID RECOVERY) investigates the role of gut microbiome in mental health and the effectiveness of personalized microbiome correction in individuals with post-traumatic stress disorder (PTSD). The study aims to: 1. identify associations between gut mic…
Phase: NA • Sponsor: Uzhhorod National University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo aims to shrink tough lung tumors
Disease control OngoingThe goal of this single arm, phase II clinical trial is to evaluate the efficacy and safety of cadonilimab (AK104) as induction and consolidation therapy in locally advanced/unresectable non-small cell lung cancer (NSCLC) patients treated with concurrent chemoradiotherapy. Parti…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New lung cancer combo aims to boost treatment completion
Disease control Recruiting nowMultinational, randomized, controlled, open-label, multicenter phase II trial. Eligible patients will be randomized in a ratio of 1:1 to Experimental Arm (FDG-PET-based small volume accelerated radiotherapy with concurrent standard of care chemotherapy) or Conventional Arm (stand…
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC